Valuation: Abbott Laboratories

Market Cap 182B 158B 148B 136B 257B 17,359B 259B 1,742B 681B 8,677B 685B 670B 28,752B P/E 2026 *
30.2x
P/E 2027 * 23.3x
Enterprise Value 207B 179B 167B 154B 291B 19,657B 294B 1,972B 771B 9,826B 776B 759B 32,559B EV / Sales 2026 *
4.11x
EV / Sales 2027 * 3.73x
Free-Float
86.16%
Yield 2026 *
2.44%
Yield 2027 * 2.6%
1 day-1.03%
1 week-3.14%
Current month+0.70%
1 month+9.59%
3 months+21.91%
6 months-0.36%
Current year-13.25%
1 week 90.76
Extreme 90.76
94.38
1 month 76.98
Extreme 76.98
96.5
Current year 70.1
Extreme 70.1
109.64
1 year 70.1
Extreme 70.1
116.14
3 years 70.1
Extreme 70.1
134.2
5 years 70.1
Extreme 70.1
134.2
10 years 49.6
Extreme 49.6
134.2
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
-1.03%-3.14% - - 185B
-0.55%-0.78%-3.84%+2.57% 111B
-0.68%-4.16%+4.30%+65.26% 60B
-1.10%+8.35%+40.75%+54.10% 53.9B
-0.05%+2.27%-4.91%-37.18% 46.9B
+3.88%+3.78% - - 34.22B
-0.42%+16.15%+14.02%-27.75% 32.95B
+0.24%+3.49%+46.30%-7.01% 24.49B
+0.09%+1.09%+1.93%+3.03% 22.67B
-1.44%-3.42%-9.73%+3.49% 21.75B
Average -0.00%+3.58%+11.10%+7.06% 45.31B
Weighted average by Cap. -0.37%+2.06%+8.64%+11.86%

Financials

2026 *2027 *
Net sales 50.3B 43.68B 40.73B 37.41B 70.76B 4,785B 71.53B 480B 188B 2,392B 189B 185B 7,926B 54.65B 47.45B 44.24B 40.64B 76.87B 5,198B 77.71B 522B 204B 2,599B 205B 201B 8,610B
Net income 6.25B 5.43B 5.06B 4.65B 8.8B 595B 8.89B 59.7B 23.34B 297B 23.49B 22.97B 985B 7.92B 6.88B 6.41B 5.89B 11.14B 754B 11.27B 75.62B 29.56B 377B 29.75B 29.1B 1,248B
Net Debt 24.17B 20.98B 19.56B 17.97B 33.99B 2,299B 34.36B 231B 90.17B 1,149B 90.75B 88.76B 3,807B 21.42B 18.6B 17.34B 15.93B 30.12B 2,037B 30.45B 204B 79.91B 1,018B 80.42B 78.66B 3,374B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change
04/08/26 €91.92 -1.03%
03/08/26 €92.88 +1.75%
31/07/26 €91.28 +0.24%
30/07/26 €91.06 -5.44%
29/07/26 €96.30 +1.48%
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
105.46USD
Average target price
118.42USD
Spread / Average Target
+12.29%

Quarterly revenue - Rate of surprise